Bolt Biotherapeutics Stock (NASDAQ: BOLT) stock price, news, charts, stock research, profile.
Open | $0.64 |
Close | $0.62 |
Volume / Avg. | 225.32K / 163.66K |
Day Range | $0.62 - $0.64 |
52 Wk Range | 0.61 - 1.56 |
Market Cap | $23.53M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 31 |
Short Interest | 0.74% |
Days to Cover | 2.32 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bolt Biotherapeutics (NASDAQ:BOLT) through any online brokerage.
Other companies in Bolt Biotherapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Palatin Techs (AMEX:PTN), Geovax Labs (NASDAQ:GOVX), Cue Biopharma (NASDAQ:CUE) and Lisata Therapeutics (NASDAQ:LSTA).
Bolt Biotherapeutics has a consensus price target of $2.38.
The stock price for Bolt Biotherapeutics (NASDAQ: BOLT) is $0.615 last updated September 20, 2024 at 4:05 PM EDT.
A quarterly cash dividend of 0.09 per share of Class A Common Stock. The quarterly cash dividend was payable on October 2, 2014 to stockholders of record on September 1, 2014.
Bolt Biotherapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Bolt Biotherapeutics.
Bolt Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.